Choon Wee Chee - 18 Sep 2025 Form 3 Insider Report for HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT)

Role
Director, 10%+ Owner
Signature
/s/ Joseph Chee
Issuer symbol
HSDT
Transactions as of
18 Sep 2025
Net transactions value
$0
Form type
3
Filing time
25 Sep 2025, 17:00:15 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Chee Choon Wee Director, 10%+ Owner C/O HELIUS MEDICAL TECHNOLOGIES, INC., 642 NEWTOWN YARDLEY RD #100, NEWTOWN /s/ Joseph Chee 25 Sep 2025 0002086036

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding HSDT COMMON STOCK 6,830,402 18 Sep 2025 By Fusion Summer Limited F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding HSDT STAPLED WARRANT 18 Sep 2025 Common Stock 6,830,402 $10.13 By Fusion Summer Limited F1, F2
holding HSDT RESTRICTED STOCK UNIT AWARD 18 Sep 2025 Common Stock 1,109,118 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Summer Wisdom Holdings Limited ("Summer Wisdom") holds all ordinary shares of Fusion Summer Limited ("Fusion Summer"). Fusion Summer holds shares of the Issuer's common stock. The Reporting Person is the Controlling Shareholder of Summer Wisdom. Summer Wisdom may be deemed to be the beneficial owner of all of the common stock held by Fusion Summer. The Reporting Person, as the Controlling Shareholder of Summer Wisdom with sole power to exercise investment discretion, may be deemed to be the beneficial owner of all of the common stock held by Fusion Summer. The Reporting Person is the Issuer's Executive Chairman of its Board of Directors.
F2 The Stapled Warrant may be exercised only during the period beginning September 18, 2025 (the "Issue Date") of the Warrant, and ending on 5:00 p.m., New York City time, on the date that is thirty-six (36) months after the Issue Date of the Warrant.
F3 The restricted stock units (RSUs) granted on September 18, 2025, are subject to the conditions set forth in the Helius Medical Technologies, Inc. 2022 Equity Incentive Plan.
F4 Each restricted stock unit represents a contingent right to receive one share of Helius Medical Technologies, Inc. Common Stock.